OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Apatinib and Ginsenoside-Rb1 Synergetically Control the Growth of Hypopharyngeal Carcinoma Cells
Yanwei Li, Feng He, Yu Zhang, et al.
Disease Markers (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 9
Yanwei Li, Feng He, Yu Zhang, et al.
Disease Markers (2022) Vol. 2022, pp. 1-14
Open Access | Times Cited: 9
Showing 9 citing articles:
Advancements and challenges in pharmacokinetic and pharmacodynamic research on the traditional Chinese medicine saponins: a comprehensive review
Yuhan Ma, Yongxia Zhao, Mingxia Luo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 8
Yuhan Ma, Yongxia Zhao, Mingxia Luo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 8
Ginsenoside Rg3: A Review of its Anticancer Mechanisms and Potential Therapeutic Applications
Lei Wu, Lin Bai, Wenshu Dai, et al.
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 10, pp. 869-884
Closed Access | Times Cited: 6
Lei Wu, Lin Bai, Wenshu Dai, et al.
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 10, pp. 869-884
Closed Access | Times Cited: 6
Ginsenoside Rb1 Inhibits the Proliferation of Lung Cancer Cells by Inducing the Mitochondrial-mediated Apoptosis Pathway
Lin Feng, Xinze Liu, Kaijing Sun, et al.
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 12, pp. 928-941
Closed Access | Times Cited: 4
Lin Feng, Xinze Liu, Kaijing Sun, et al.
Anti-Cancer Agents in Medicinal Chemistry (2024) Vol. 24, Iss. 12, pp. 928-941
Closed Access | Times Cited: 4
Ginsenoside CK Promotes Cell Apoptosis via Regulating P53 Signal Pathway in Non‐Small Cell Lung Cancer
Xinze Liu, Lin Feng, Xin Jin, et al.
Drug Development Research (2025) Vol. 86, Iss. 2
Closed Access
Xinze Liu, Lin Feng, Xin Jin, et al.
Drug Development Research (2025) Vol. 86, Iss. 2
Closed Access
Integrating Chinese medicine into mainstream cancer therapies: a promising future
Baoyi Ni, Kaiyuan Xue, Jia Wang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Baoyi Ni, Kaiyuan Xue, Jia Wang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 3
Research progress of ginseng in the treatment of gastrointestinal cancers
Baoyi Ni, Xiaotong Song, Bolun Shi, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 14
Baoyi Ni, Xiaotong Song, Bolun Shi, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 14
Anti-cancer effect and potential microRNAs targets of ginsenosides against breast cancer
Meiling Fan, Mengyao Shan, Xintian Lan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Meiling Fan, Mengyao Shan, Xintian Lan, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 11
Research Progress on Anti‐Inflammatory Mechanisms of Black Ginseng
Ran Huo, Mengyuan Wang, Wei Xu, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 3
Open Access | Times Cited: 3
Ran Huo, Mengyuan Wang, Wei Xu, et al.
Chemistry & Biodiversity (2023) Vol. 20, Iss. 3
Open Access | Times Cited: 3
Ginsenosides: Allies of gastrointestinal tumor immunotherapy
Yutao Feng, Fen Ma, Enjiang Wu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 5
Yutao Feng, Fen Ma, Enjiang Wu, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 5
